The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Fagus Antibody Services
Oxford, United Kingdom
A
1-10 Employees
2022
Key takeaway
Fagus Antibody Services offers a range of products, including an Acetylcholinesterase (AChE) Rabbit polyclonal antibody. AChE plays a crucial role in hydrolyzing acetylcholine at neuromuscular junctions and cholinergic synapses, thereby terminating signal transmission.
Reference
Product
AChE Rabbit pAb - Fagus Antibody Services
Acetylcholinesterase hydrolyzes the neurotransmitter, acetylcholine at neuromuscular junctions and brain cholinergic synapses, and thus terminates signal transmission. It is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen. Acetylcholinesterase exists in multiple molecular forms which possess similar catalytic properties, but differ in their oligomeric assembly and mode of
Genebio
-
- Employees
-
Key takeaway
GeneBio Systems offers Recombinant Bovine Acetylcholinesterase (ACHE), a product relevant for research in Molecular and Cellular Biology. Their commitment to providing high-performance laboratory products supports both clinical and academic research needs.
Reference
Product
Recombinant Bovine Acetylcholinesterase(ACHE) – GeneBio Systems
Recombinant Bovine Acetylcholinesterase(ACHE)
Wieslab a Svar Life Science company
Malmo, Sweden
A
11-50 Employees
1992
Key takeaway
The company offers a comprehensive range of tests, including acetylcholine receptor antibodies, which are relevant to the study of acetylcholinesterase. Their commitment to advancing scientific discovery through innovative assays supports drug development and clinical diagnostics.
Reference
Service
Acetylcholine receptor antibodies
We help customers with clinical testing, offering a comprehensive range of individual tests and test panels and support for therapeutic drug monitoring.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
EPCA
Brussels, Belgium
A
1-10 Employees
1967
Key takeaway
The company, EPCA, serves as a platform for sharing ideas and knowledge among key industry players, focusing on sustainability and environmental challenges.
Reference
Core business
Aceto | EPCA
Activotec
Cambridge, United Kingdom
A
- Employees
-
Key takeaway
Activotec specializes in high purity amino acid derivatives and custom peptide synthesis, which may be relevant for research involving acetylcholinesterase. Their expertise in peptide chemistries and innovative synthesis methods could support projects related to this enzyme.
Reference
Product
Ac-His(Trt)-OH - Activotec
Athens Research & Technology
Athens-Clarke County Unified Government, United States
B
11-50 Employees
1986
Key takeaway
Athens Research & Technology manufactures highly pure and active human proteins, including butyrylcholinesterase from human plasma, which may be relevant for studies related to Alzheimer's Disease and other conditions.
Reference
Product
Butyrylcholinesterase, Human Plasma | Athens Research & Technology
Conscientia Industrial Co. Ltd
Taizhou, China
D
51-100 Employees
2003
Key takeaway
Conscientia Industrial Co., Ltd is a prominent manufacturer and supplier of Acetyl Decapeptide-3, which may be of interest when exploring related compounds or applications in pharmaceuticals.
Reference
Product
Acetyl Decapeptide-3 Manufacturer | Supplier | Provider
Conscientia Industrial is Acetyl Decapeptide-3 CAS 935288-50-9 manufacturer supplier in China
Gecco Biotech B.V.
Groningen, Netherlands
A
1-10 Employees
-
Key takeaway
Gecco Biotech specializes in developing sustainable enzymatic solutions across various fields, including pharmaceuticals. Their expertise in enzyme discovery and engineering may be relevant for applications involving acetylcholinesterase.
Reference
Core business
transaminase_web - Gecco Biotech
ACS PharmaProtect GmbH
Berlin, Germany
A
11-50 Employees
2012
Key takeaway
The ACS PharmaProtect GmbH is responsible for the database system of the pharmaceutical industry in Germany, highlighting their role in ensuring secure processes and systems. This focus on safety and verification in the pharmaceutical market may be relevant to the context of acetylcholinesterase research and applications.
Reference
Core business
ACS PharmaProtect - für mehr Sicherheit im Arzneimittelmarkt
Die ACS ist ein Unternehmen der vier großen deutschen Pharmaverbände und Teil der securPharm für die Echtheitsprüfung von Arzneimitteln.
Neuro-Bio
Vale of White Horse, United Kingdom
A
11-50 Employees
2013
Key takeaway
Neuro-Bio, a biotech company focused on neurodegenerative diseases, is actively researching Acetylcholinesterase (AChE) and its properties in both neuronal and non-neuronal cells. This research supports their development of innovative drugs aimed at treating Alzheimer's disease.
Reference
Core business
Neuro-Bio's Research Of AChE Present In Neuronal & Non-Neuronal Cells
Neuro-Bio development comes from the research & discovery of the properties and behavioural actions of Acetylcholinesterase (AChE).
Technologies which have been searched by others and may be interesting for you:
Acetylcholinesterase is an enzyme that plays a critical role in the nervous system by breaking down the neurotransmitter acetylcholine. This process is essential for the proper functioning of synapses, as it ensures that the signal between nerve cells is terminated efficiently. By hydrolyzing acetylcholine into acetate and choline, acetylcholinesterase helps prevent continuous stimulation of muscles and nerves, which could lead to muscle spasms or paralysis. The enzyme is widely studied for its implications in various neurological disorders and is also a target for certain drugs and pesticides, making its providers vital for research and therapeutic applications.
Acetylcholinesterase is an enzyme that plays a crucial role in the nervous system by breaking down the neurotransmitter acetylcholine. Once acetylcholine is released into the synaptic cleft, it binds to receptors on the postsynaptic neuron, facilitating the transmission of nerve impulses. After its action, acetylcholine must be rapidly removed to prevent continuous stimulation of the neuron. Acetylcholinesterase catalyzes the hydrolysis of acetylcholine into acetate and choline, effectively terminating the signal and allowing the neuron to reset for the next impulse. This regulation is essential for proper muscle function and maintaining the overall balance of neurotransmission in the body.
Acetylcholinesterase is a crucial enzyme in the process of neurotransmission, particularly within the cholinergic system. It is responsible for the rapid breakdown of the neurotransmitter acetylcholine in the synaptic cleft, which is essential for terminating synaptic transmission. By hydrolyzing acetylcholine into acetate and choline, acetylcholinesterase ensures that neurotransmitter signaling is tightly regulated, preventing continuous stimulation of post-synaptic receptors. This rapid degradation is vital for muscle relaxation and overall neural function, facilitating precise communication between neurons and muscle fibers.
Inhibitors of acetylcholinesterase are primarily utilized in the treatment of various neurological disorders. These compounds work by blocking the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine. As a result, they increase the availability of acetylcholine in the synaptic cleft, enhancing cholinergic transmission. Such inhibitors are particularly effective in managing conditions like Alzheimer's disease, where they help improve cognitive function and memory by facilitating better communication between neurons. Additionally, these inhibitors are used in the treatment of myasthenia gravis, a condition characterized by muscle weakness due to insufficient acetylcholine action at the neuromuscular junction.
Acetylcholinesterase plays a crucial role in muscle contraction by regulating the levels of acetylcholine, a neurotransmitter essential for muscle activation. When a nerve impulse reaches the neuromuscular junction, acetylcholine is released, binding to receptors on the muscle cell membrane, leading to muscle contraction. After this process, acetylcholinesterase rapidly breaks down acetylcholine into acetate and choline, terminating its action. This breakdown is vital as it prevents continuous stimulation of the muscle, allowing it to relax after contraction. Without proper functioning of acetylcholinesterase, acetylcholine could accumulate, resulting in prolonged muscle contraction or spasms, which can hinder normal muscle function.
Some interesting numbers and facts about your company results for Acetylcholinesterase
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 1746 |
| Amount of suitable service providers | 1669 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1967 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Acetylcholinesterase
What are related technologies to Acetylcholinesterase?
Based on our calculations related technologies to Acetylcholinesterase are Aromatics, Desiccants, Refrigerants, Resins, Green Chemistry
Who are Start-Ups in the field of Acetylcholinesterase?
Start-Ups who are working in Acetylcholinesterase are Fagus Antibody Services
Which industries are mostly working on Acetylcholinesterase?
The most represented industries which are working in Acetylcholinesterase are Other, Biotechnology, Pharmaceuticals, IT, Software and Services, Chemicals
How does ensun find these Acetylcholinesterase Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
